140 related articles for article (PubMed ID: 20040858)
1. Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease.
Cakal B; Gokmen A; Yalinkilic M; Cakal E; Ayaz S; Nadir I; Ozin Y; Dagli U; Ulker A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):118-21. PubMed ID: 20040858
[TBL] [Abstract][Full Text] [Related]
2. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
[TBL] [Abstract][Full Text] [Related]
3. The search for a common thrombophilic state during the active state of inflammatory bowel disease.
Yurekli BP; Aksoy DY; Aybar M; Egesel T; Gurgey A; Hascelik G; Kirazli S; Haznedaroglu IC; Arslan S
J Clin Gastroenterol; 2006 Oct; 40(9):809-13. PubMed ID: 17016137
[TBL] [Abstract][Full Text] [Related]
4. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Vasiliadis T; Giouleme O; Evgenidis N
Hepatogastroenterology; 2007; 54(77):1417-21. PubMed ID: 17708267
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
10. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
[TBL] [Abstract][Full Text] [Related]
11. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
Folwaczny C; Wiebecke B; Loeschke K
Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
[TBL] [Abstract][Full Text] [Related]
12. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
13. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
15. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
[TBL] [Abstract][Full Text] [Related]
16. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
17. Serum gastrin levels in patients with inflammatory bowel disease.
Triantafillidis JK; Tzourmakliotis D; Peros G; Merikas E; Barbatzas C; Cheracakis P; Gikas A; Konstandellou E
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccxv-cccxvii. PubMed ID: 15244213
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation.
Naftali T; Novick D; Gabay G; Rubinstein M; Novis B
Isr Med Assoc J; 2007 Jul; 9(7):504-8. PubMed ID: 17710779
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
[TBL] [Abstract][Full Text] [Related]
20. The serum concentrations of zinc, copper and selenium in children with inflammatory bowel disease.
Ojuawo A; Keith L
Cent Afr J Med; 2002; 48(9-10):116-9. PubMed ID: 14562534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
